Advancements in Patient-Centered Care

NCODA Featured in Specialty Pharmacy Continuum on Medically Integrated Oncology Pharmacy

September 2, 2026

NCODA’s Jonas Congelli discusses the patient-care benefits and evolving future of medically integrated oncology pharmacy in Specialty Pharmacy Continuum.

Expanding Access to CAR-T Therapy Operational Models and Best Practices Across the Oncology Care Continuum

September 2, 2026

The landscape for chimeric antigen receptor T-cell (CAR-T) therapy is evolving, with growing use in earlier lines of treatment, expanding outpatient administration, and a widening range of practice settings taking on delivery. But translating these advances into everyday practice can bring real operational, logistical, and coordination challenges.

Shifting Treatment Perspectives in Polycythemia Vera Real-World Experience with Ropeginterferon Alfa-2b

August 21, 2026

The treatment landscape for polycythemia vera (PV) is evolving, with growing emphasis on long-term disease control, earlier use of interferon-based therapy, and individualized treatment strategies. But translating these advances into everyday practice can bring real operational and patient-care challenges.

NCODA Urges CMS to Reconsider Proposed QSSD Policy for Fixed-Combination New Formulations

NCODA has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding its proposed policy for the treatment of certain fixed-combination new formulations under the Medicare Drug Price Negotiation Program.

Keeping Cancer Care Close to Home

August 4, 2026

NCODA Associate Executive Director Jonas Congelli joins oncology leaders in examining access barriers, practice sustainability, and what it takes to keep advanced cancer care close to home.

“This Is a Problem”: Oncologists Concerned Over Chemotherapy Shortages

July 23, 2026

NCODA and Cureety partner to integrate evidence-based Patient Chemotherapy drug shortages continue to impact cancer care. Read expert perspectives from NCODA and other oncology leaders on challenges and potential solutions. Sheets into oncology workflows, supporting patient-centered care.

Connecting clinical knowledge with care delivery: NCODA and Cureety partner to bring trusted regimen guidance at the point of care  

July 23, 2026

NCODA and Cureety partner to integrate evidence-based Patient Education Sheets into oncology workflows, supporting patient-centered care.

NCODA Position Statement on 340B:  The Benefit Must Follow Patients 

The future of 340B should be defined by patient benefit, not organizational participation. NCODA’s position statement calls for reforms that ensure the benefit follows the patient and that program success is measured by improved access, affordability, and patient outcomes.

Beyond Precision Medicine: Why Personalized Care Delivery Matters in Oncology

June 17, 2026

Precision oncology goes beyond selecting the right therapy. In this guest editorial, Cureety explores how proactive symptom monitoring, patient-reported outcomes, and digital health tools can help oncology teams deliver more responsive, patient-centered care.

Cortisol in Oncology: An Emerging Area of Scientific Inquiry

May 29, 2026

What role might stress biology play in cancer care? This article explores emerging research on glucocorticoid receptor (GR) signaling and its potential impact on tumor biology and treatment response.